Gerard Aurigemma to Atenolol
This is a "connection" page, showing publications Gerard Aurigemma has written about Atenolol.
Connection Strength
0.051
-
Bang CN, Gerdts E, Aurigemma GP, Boman K, de Simone G, Dahl?f B, K?ber L, Wachtell K, Devereux RB. Four-group classification of left ventricular hypertrophy based on ventricular concentricity and dilatation identifies a low-risk subset of eccentric hypertrophy in hypertensive patients. Circ Cardiovasc Imaging. 2014 May; 7(3):422-9.
Score: 0.029
-
Wachtell K, Gerdts E, Aurigemma GP, Boman K, Dahl?f B, Nieminen MS, Olsen MH, Okin PM, Palmieri V, Rokkedal JE, Devereux RB. In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study. Blood Press. 2010 Jun; 19(3):169-75.
Score: 0.022